Seguir
Rajmohan Murali
Título
Citado por
Citado por
Año
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
VK Arora, E Schenkein, R Murali, SK Subudhi, J Wongvipat, MD Balbas, ...
Cell 155 (6), 1309-1322, 2013
10642013
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
F Azimi, RA Scolyer, P Rumcheva, M Moncrieff, R Murali, SW McCarthy, ...
Journal of Clinical Oncology 30 (21), 2678-2683, 2012
9142012
Germline mutations in BAP1 predispose to melanocytic tumors
T Wiesner, AC Obenauf, R Murali, I Fried, KG Griewank, P Ulz, ...
Nature genetics 43 (10), 1018-1021, 2011
8072011
Classification of endometrial carcinoma: more than two types
R Murali, RA Soslow, B Weigelt
The Lancet Oncology 15 (7), e268-e278, 2014
7672014
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
DM Hyman, SA Piha-Paul, H Won, J Rodon, C Saura, GI Shapiro, D Juric, ...
Nature 554 (7691), 189-194, 2018
7592018
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
T Wiesner, J He, R Yelensky, R Esteve-Puig, T Botton, I Yeh, D Lipson, ...
Nature communications 5, 3116, 2014
6302014
Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan, BS Carver, MT Chang, Y Xiao, ...
Proceedings of the National Academy of Sciences 111 (30), 11139-11144, 2014
3982014
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
S Shah, KA Schrader, E Waanders, AE Timms, J Vijai, C Miething, ...
Nature genetics 45 (10), 1226-1231, 2013
3662013
Tumours associated with BAP1 mutations
R Murali, T Wiesner, RA Scolyer
Pathology 45 (2), 116-126, 2013
3212013
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
T Wiesner, R Murali, I Fried, L Cerroni, K Busam, H Kutzner, BC Bastian
The American journal of surgical pathology 36 (6), 818-830, 2012
3132012
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
H Hieronymus, R Murali, A Tin, K Yadav, W Abida, H Moller, D Berney, ...
eLife 7, e37294, 2018
2922018
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
KG Griewank, R Murali, JA Puig-Butille, B Schilling, E Livingstone, ...
Journal of the National Cancer Institute 106 (9), dju246, 2014
2912014
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
J Bauer, P Büttner, R Murali, I Okamoto, NA Kolaitis, MT Landi, ...
Pigment cell & melanoma research 24 (2), 345-351, 2011
2812011
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
AH Shain, M Garrido, T Botton, E Talevich, I Yeh, JZ Sanborn, J Chung, ...
Nature genetics 47 (10), 1194-1199, 2015
2722015
Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, ...
Clinical Cancer Research 23 (21), 6708-6720, 2017
2592017
High-grade endometrial carcinomas: Morphologic and immunohistochemical features, diagnostic challenges and recommendations
R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ...
International Journal of Gynecological Pathology 38 (1 Suppl 1), S40, 2019
2562019
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ...
International Journal of Gynecological Pathology 38 (1 Suppl 1), S40, 2019
2562019
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ...
Nature 526 (7573), 453-457, 2015
2512015
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018
2482018
Squamous precursor lesions of the vulva: current classification and diagnostic challenges
LN Hoang, KJ Park, RA Soslow, R Murali
Pathology 48 (4), 291-302, 2016
2262016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20